MENU
+Compare
IXHL
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$0.20
Change
-$0.01 (-4.76%)
Capitalization
56.83M

IXHL Incannex Healthcare Forecast, Technical & Fundamental Analysis

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions... Show more

IXHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IXHL with price predictions
Jun 27, 2025

IXHL's Stochastic Oscillator dives oversold zone

The Stochastic Oscillator for IXHL moved into oversold territory on June 27, 2025. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IXHL advanced for three days, in of 162 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 27, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on IXHL as a result. In of 46 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IXHL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.011) is normal, around the industry mean (62.813). P/E Ratio (0.000) is within average values for comparable stocks, (89.433). IXHL's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.124) among similar stocks. IXHL's P/S Ratio (357.143) is very high in comparison to the industry average of (19.290).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. IXHL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IXHL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
IXHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
8 Century Circuit Norwest
Phone
+61 425703805
Employees
10
Web
https://www.incannex.com.au
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XRAY15.930.09
+0.57%
DENTSPLY SIRONA
GS690.813.65
+0.53%
Goldman Sachs Group
VMD6.920.01
+0.14%
Viemed Healthcare
EXPI9.270.01
+0.11%
eXp World Holdings
ICCM1.01-0.01
-0.63%
IceCure Medical Ltd

IXHL and Stocks

Correlation & Price change

A.I.dvisor tells us that IXHL and ESPR have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IXHL and ESPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IXHL
1D Price
Change %
IXHL100%
-1.96%
ESPR - IXHL
23%
Poorly correlated
-2.75%
NBIX - IXHL
22%
Poorly correlated
-1.02%
HROW - IXHL
22%
Poorly correlated
-1.53%
YCBD - IXHL
20%
Poorly correlated
+3.78%
RDY - IXHL
14%
Poorly correlated
-1.70%
More